Sacristán Santos, V., Pensado López, A., García Campelo, R., Antolín Novoa, S., Señarís Rodríguez, R. M., & Torres Andón, F. (2025). Reprogramming tumor-associated macrophages using STING or TLR agonists: A promising strategy to enhance immunotherapy in hormonedependent cancers.
Citación estilo ChicagoSacristán Santos, Víctor, Alba Pensado López, Rosario García Campelo, Silvia Antolín Novoa, Rosa María Señarís Rodríguez, y Fernando Torres Andón. Reprogramming Tumor-associated Macrophages Using STING or TLR Agonists: A Promising Strategy to Enhance Immunotherapy in Hormonedependent Cancers. 2025.
Cita MLASacristán Santos, Víctor, et al. Reprogramming Tumor-associated Macrophages Using STING or TLR Agonists: A Promising Strategy to Enhance Immunotherapy in Hormonedependent Cancers. 2025.